APRE Stock Analysis: Buy, Sell, or Hold?
APRE - Aprea Therapeutics, Inc. Common stock
$0.60
0.00 (0.40%)
▲
5d:
-2.22%
30d:
-19.99%
90d:
-28.63%
HOLD
MODERATE Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Aug 11, 2026
6d
Get Alerted When APRE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: APRE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: APRE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: APRE is currently trading at $0.60, which is considered oversold relative to its 30-day fair value range of $0.63 to $0.76.
Technical Outlook: Technically, APRE is in a downtrend. The price is currently testing key support at $0.59. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: APRE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $4.30 (+619.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, APRE is in a downtrend. The price is currently testing key support at $0.59. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: APRE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $4.30 (+619.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.63 -
$0.76
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 619.4% below Wall St target ($4.30)
Trading Range Analysis
30-Day Trading Range
$0.63 -
$0.76
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.59
Resistance Level
$0.71
Current Trend
Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.76
Wall Street Target
$4.30
(+619.4%)
Revenue Growth (YoY)
-98.4%
Share & Embed Analysis
Last updated: August 04, 2026 9:50 AM ET
Data refreshes hourly during market hours. Next update: 10:50 AM
Data refreshes hourly during market hours. Next update: 10:50 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APRE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 55 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$123 | 54 HOLD |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$102 | 60 BUY |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$147 | 60 BUY |
